molybdenum has been researched along with Fibrosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| El-Waseif, EG; Sharawy, MH; Suddek, GM | 1 |
| Cao, H; Dai, X; Li, Z; Liao, H; Liu, Z; Peng, C; Shan, J; Wang, H; Yang, F; Zhang, T | 1 |
| Brewer, GJ | 2 |
| Brewer, GJ; Dick, R; Hou, G; Zeng, C | 1 |
| Arteel, GE; Barve, S; Brewer, GJ; Chen, T; Liu, M; McClain, CJ; Song, M; Song, Z; Zhang, J | 1 |
2 review(s) available for molybdenum and Fibrosis
| Article | Year |
|---|---|
The risks of free copper in the body and the development of useful anticopper drugs.
Topics: Alzheimer Disease; Angiogenesis Inhibitors; Autoimmunity; Copper; Fibrosis; Hepatolenticular Degeneration; Humans; Inflammation; Molybdenum; Neurodegenerative Diseases; Penicillamine; Trientine | 2008 |
Anticopper therapy against cancer and diseases of inflammation and fibrosis.
Topics: Animals; Copper; Fibrosis; Humans; Inflammation; Molybdenum; Neoplasms; Neovascularization, Pathologic; Penicillamine; Trientine | 2005 |
4 other study(ies) available for molybdenum and Fibrosis
| Article | Year |
|---|---|
The modulatory effect of sodium molybdate against cisplatin-induced CKD: Role of TGF-β/Smad signaling pathway.
Topics: Animals; Cisplatin; Fibrosis; Inflammation; Molybdenum; NF-kappa B; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2022 |
Role of Caveolin-1 on the molybdenum and cadmium exposure induces pulmonary ferroptosis and fibrosis in the sheep.
Topics: Animals; beta Catenin; Cadmium; Caveolin 1; Ferroptosis; Fibrosis; Humans; Infant; Lung; Molybdenum; Sheep | 2023 |
The use of tetrathiomolybdate in treating fibrotic, inflammatory, and autoimmune diseases, including the non-obese diabetic mouse model.
Topics: Animals; Autoimmune Diseases; Diabetes Mellitus, Type 1; Disease Models, Animal; Fibrosis; Inflammation; Mice; Mice, Inbred NOD; Molybdenum; Obesity | 2006 |
Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Bile Ducts; Bilirubin; Ceruloplasmin; Cholestasis; Copper; Disease Models, Animal; Fibrosis; gamma-Glutamyltransferase; Gene Expression; Ligation; Liver; Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Molybdenum; Protective Agents; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2008 |